A Novel Method for Ex Vivo Stimulation of Mesenchymal Stem Cells via Invariant Natural Killer T Cell Activation with α-Galactosylceramide.

被引：0
|
作者：
Ishii, R. [1 ]
Kawaguchi, E. [1 ]
Yamakawa, T. [1 ]
Ishigooka, H. [1 ]
Ikeda, T. [1 ]
Ishiyama, R. [1 ]
Saiga, K. [1 ]
Takagi, T. [1 ]
Ishii, Y. [2 ]
Tanabe, K. [1 ]
机构：
[1] Tokyo Womens Med Univ, Tokyo, Japan
[2] Juntendo Univ, Grad Sch Med, Dept Immunol Diag, Tokyo, Japan
来源：
AMERICAN JOURNAL OF TRANSPLANTATION | 2022年 / 22卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
C61
引用
收藏
页码：898 / 899
页数：2
相关论文
共 50 条
  • [21] Activation of invariant natural killer T cells by alpha-galactosylceramide ameliorates doxorubicin-induced cardiotoxicity in mice
    Obata, Yoshikuni
    Ishimori, Naoki
    Saito, Akimichi
    Kinugawa, Shintaro
    Yokota, Takashi
    Takada, Shingo
    Nakano, Ippei
    Kakutani, Naoya
    Yamanashi, Katsuma
    Anzai, Toshihisa
    EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2020, 27 (19) : 2358 - 2361
  • [22] Activation of invariant natural killer T cells by alpha-galactosylceramide ameliorates doxorubicin-induced cardiotoxicity in mice
    Obata, Y.
    Ishimori, N.
    Saito, A.
    Kinugawa, S.
    Nakano, I.
    Kakutani, N.
    Yamanashi, K.
    Anzai, T.
    EUROPEAN HEART JOURNAL, 2019, 40 : 925 - 925
  • [23] In Vivo Inverse Correlation in the Activation of Natural Killer T Cells Through Dual-Signal Stimulation via a Combination of α-Galactosylceramide-Loaded Liposomes and Interleukin-12
    Abdelmegeed, Heba
    Nakamura, Takashi
    Harashima, Hideyoshi
    JOURNAL OF PHARMACEUTICAL SCIENCES, 2016, 105 (01) : 250 - 256
  • [24] The Use of Ex Vivo Expanded Human Invariant Natural Killer T Cells as a Novel Cell Therapy to Modulate Graft-Versus-Host-Disease
    Im, Jin Seon
    He, Hong
    Rezvani, Katy
    Shpall, Elizabeth J.
    Ma, Qing
    Molldrem, Jeffrey
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2016, 22 (03) : S399 - S399
  • [25] Activation mechanisms of invariant natural killer T cells (iNKTs)
    Baena, Andres
    Gomez-Giraldo, Lina
    Carreno, Leandro J.
    IATREIA, 2016, 29 (01) : 51 - 64
  • [26] Added effects of dexamethasone and mesenchymal stem cells on early Natural Killer cell activation
    Michelo, Clive M.
    Fasse, Esther
    Van Cranenbroek, Bram
    Linda, Katrin
    van der Meer, Arnold
    Abdelrazik, Heba
    Joosten, Irma
    TRANSPLANT IMMUNOLOGY, 2016, 37 : 1 - 9
  • [27] Stem cell-engineered invariant natural killer T cells for cancer therapy
    Yang, Lili
    Smith, Drake
    Liu, Siyuan
    Ji, Sunjong
    Liu, Bo
    CANCER RESEARCH, 2017, 77
  • [28] Facile synthesis of biotin-labelled α-galactosylceramide as antigen for invariant natural killer T cells
    Xia, Chengfeng
    Zhang, Wenpeng
    Zhang, Yalong
    Woodward, Robert L.
    Wang, Jinhua
    Wang, Peng G.
    TETRAHEDRON, 2009, 65 (32) : 6390 - 6395
  • [29] ACTIVATION OF NATURAL KILLER T CELLS BY ALPHA-GALACTOSYLCERAMIDE AFFECTS IRON METABOLISM
    Huang, Hua
    Fragoso, Gabriela
    Santos, Manuela
    AMERICAN JOURNAL OF HEMATOLOGY, 2013, 88 (05) : E127 - E127
  • [30] Rapid ex vivo expansion of highly enriched human invariant natural killer T cells via single antigenic stimulation for cell therapy to prevent graft-versus-host disease
    Trujillo-Ocampo, Abel
    Cho, Hyun-Woo
    Herrmann, Amanda C.
    Ruiz-Vazquez, Wilfredo
    Thornton, Andrew B.
    He, Hong
    Li, Dan
    Qazilbashi, Mariam A.
    Ma, Qing
    Porcelli, Steven A.
    Shpall, Elizabeth J.
    Molldrem, Jeffrey
    Im, Jin S.
    CYTOTHERAPY, 2018, 20 (08) : 1089 - 1101
12345